home / lobbying / lobbying_filings_raw

lobbying_filings_raw: c10ca00c-703c-4b68-b0ea-53d3e0d607d4

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence income_amount expense_amount
c10ca00c-703c-4b68-b0ea-53d3e0d607d4 Q1 7053 BRISTOL-MYERS SQUIBB COMPANY 109642 BRISTOL-MYERS SQUIBB COMPANY 2009 first_quarter 2009-04-17T15:11:06-04:00 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/c10ca00c-703c-4b68-b0ea-53d3e0d607d4/", "filing_uuid": "c10ca00c-703c-4b68-b0ea-53d3e0d607d4", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2009, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/c10ca00c-703c-4b68-b0ea-53d3e0d607d4/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "814676.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Richard L. Thompson, Senior Vice President of Policy & Government Affairs", "dt_posted": "2009-04-17T15:11:06-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "655 15TH STREET, NW, #300", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 7053, "url": "https://lda.senate.gov/api/v1/registrants/7053/", "house_registrant_id": 31580, "name": "BRISTOL-MYERS SQUIBB COMPANY", "description": "Lobbying on biopharmaceutical issues.", "address_1": "801 Pennsylvania Ave, NW, Suite 745", "address_2": null, "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "LAURA DAVIS EIDSON", "contact_telephone": "+1 727-519-5721", "dt_updated": "2026-01-30T12:07:02.522051-05:00"}, "client": {"id": 109642, "url": "https://lda.senate.gov/api/v1/clients/109642/", "client_id": 12, "name": "BRISTOL-MYERS SQUIBB COMPANY", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2013-05-21"}, "lobbying_activities": [{"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "NO BILL Tax Reform. Lobbied to gather information on potential legislation regarding deferral of foreign income.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 24699, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CAROZZA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5959, "prefix": null, "prefix_display": null, "first_name": "RICHARD", "nickname": null, "middle_name": null, "last_name": "THOMPSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "S. 515 and H.R.1260, Patent Reform Act of 2009. Lobbied Members of Congress to improve provisions related to inequitable conduct and damages. H.R. 1706, Protecting Consumer Access to Generic Drugs Act. Lobbied Members of Congress to protect access to safe and affordable prescription drugs.\nS. 369, Preserve Access to Affordable Generics Act. Lobbied Members of Congress to protect access to safe and affordable prescription drugs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5959, "prefix": null, "prefix_display": null, "first_name": "RICHARD", "nickname": null, "middle_name": null, "last_name": "THOMPSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs.\nH.R. 1548, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity.\nS. 525 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs.\nH.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program.\nH.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs\nH.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.\nH.R. 1298/ S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 24699, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CAROZZA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5959, "prefix": null, "prefix_display": null, "first_name": "RICHARD", "nickname": null, "middle_name": null, "last_name": "THOMPSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.\nH.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D.\nH.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act. Lobbied for passage of the bill.\nH.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills.\nH.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D.\n4S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 24699, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CAROZZA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 5959, "prefix": null, "prefix_display": null, "first_name": "RICHARD", "nickname": null, "middle_name": null, "last_name": "THOMPSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "H.Con.Res 85, S.Con.Res 13, House and Senate Budget Resolutions. Lobbied Members of Congress to ensure safety and access to prescription drugs.\nH.Con.Res 85, Function 150, House and Senate Budget Resolutions. Lobbied Members of Congress to keep the current International Affairs FY 2010 Budget.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 24699, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CAROZZA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 39456, "prefix": null, "prefix_display": null, "first_name": "CHRISTOPHER", "nickname": null, "middle_name": null, "last_name": "PERNIE", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 36053, "prefix": null, "prefix_display": null, "first_name": "LANE", "nickname": null, "middle_name": null, "last_name": "PENRY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 3182, "prefix": "mr", "prefix_display": "MR.", "first_name": "DAVID", "nickname": null, "middle_name": "E", "last_name": "WARR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CSP", "general_issue_code_display": "Consumer Issues/Safety/Products", "description": "NO BILL, Bisphenol A (BPA). Lobbied Members of Congress regarding BPA in containers.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 24699, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CAROZZA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "WEL", "general_issue_code_display": "Welfare", "description": "NO BILL, WIC Program. Lobbied on reauthorization of WIC Program.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 24699, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": null, "last_name": "CAROZZA", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US 31580 DC DC US US   0 0           814676.0

Links from other tables

  • 7 rows from filing_uuid in lobbying_activities
  • 5 rows from filing_uuid in lobbying_lobbyists
  • 0 rows from filing_uuid in lobbying_affiliated_orgs
Powered by Datasette · Queries took 0.291ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API